Distal Trisomy 20q C4706935
A genetic condition resulting from extra material at the tip of chromosome 20. Individuals may experience developmental delays, distinctive facial features, and various health concerns. Care involves addressing specific medical needs with a multidisciplinary team.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Congenital heart defect
Generalized symptoms
(congenital)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Developmental delay
(nervous_system)Skeletal dysplasia
(musculoskeletal)Skin hypoplasia
(integumentary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Multisystem Health Surveillance Program
Coordinated monitoring for endocrine disorders, renal anomalies, and autoimmune conditions that may occur with distal trisomy 20q, with regular laboratory and imaging assessments as indicated.
Motor Development Enhancement Program
Therapeutic interventions focusing on improving muscle tone, coordination, balance, and functional mobility in individuals with distal trisomy 20q experiencing motor delays and coordination difficulties.
Additional treatment options
Endocrine Disorder Management
Pharmacologic treatment and monitoring of endocrine manifestations such as thyroid dysfunction, growth hormone deficiency, or diabetes that may accompany distal trisomy 20q.
medicationIndividualized Education and Social Support
Specialized educational planning with appropriate classroom accommodations, social skills training, and vocational preparation to maximize learning potential and community integration.
lifestyleIntegrative Support Services
Complementary therapies including music therapy, art therapy, and animal-assisted interventions to support emotional well-being, communication, and quality of life in individuals with distal trisomy 20q.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Distal Trisomy 20q C4706935?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Distal Trisomy 20q C4706935. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy